These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 16835496

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A case of recurrent gastrointestinal stromal tumor with complete response from treatment with reduced dose of imatinib mesylate].
    Toyokawa T, Yamashita Y, Yamamoto A, Shimizu S, Inoue T, Ikehara T, Sakashita K, Kanehara I, Teraoka H, Nishiguchi Y.
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1723-5. PubMed ID: 23152028
    [Abstract] [Full Text] [Related]

  • 6. [A case of recurrent GIST successfully treated with low-dose imatinib mesilate].
    Hanada N, Kawamura Y, Taneda T, Yoshida Y, Osako T, Inoue K.
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):799-801. PubMed ID: 16770100
    [Abstract] [Full Text] [Related]

  • 7. Gastric antral vascular ectasia in a patient with GIST after treatment with imatinib: case report and literature review.
    Saad Aldin E, Mourad F, Tfayli A.
    Jpn J Clin Oncol; 2012 May; 42(5):447-50. PubMed ID: 22422898
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case.
    Ando Y, Tsunoda T, Beck Y, Takayama T, Tahara H.
    Surg Today; 2005 May; 35(2):157-60. PubMed ID: 15674500
    [Abstract] [Full Text] [Related]

  • 10. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
    Hanada N, Kawata K, Okamura S, Tomiyama N, Hori K.
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
    [Abstract] [Full Text] [Related]

  • 11. Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.
    Blay JY, Le Cesne A, Ray-Coquard I, Bui B, Duffaud F, Delbaldo C, Adenis A, Viens P, Rios M, Bompas E, Cupissol D, Guillemet C, Kerbrat P, Fayette J, Chabaud S, Berthaud P, Perol D.
    J Clin Oncol; 2007 Mar 20; 25(9):1107-13. PubMed ID: 17369574
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively].
    Okuda H, Tanaka H, Ueno M, Shitani M, Nasuno M, Suzuki C, Nishimura S, Kimura H, Yonezawa K, Abe T, Yoshida Y, Kawabata M.
    Gan To Kagaku Ryoho; 2005 Nov 20; 32(12):1941-4. PubMed ID: 16282731
    [Abstract] [Full Text] [Related]

  • 17. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.
    Rutkowski P, Nowecki Z, Nyckowski P, Dziewirski W, Grzesiakowska U, Nasierowska-Guttmejer A, Krawczyk M, Ruka W.
    J Surg Oncol; 2006 Mar 15; 93(4):304-11. PubMed ID: 16496358
    [Abstract] [Full Text] [Related]

  • 18. [Neoadjuvant therapy with imatinib mesilate for gastrointestinal stromal tumor of the stomach before subsequent successful surgical resection].
    Yamamoto K, Imamura H, Furukawa H, Kishimoto T, Miyazaki Y, Ohshiro R, Tatsuta M, Ohsato H, Fukunaga M, Nakayama T, Fujimi S, Takemoto H, Kondo M, Kamigaki S, Ohta K, Nakata Y.
    Gan To Kagaku Ryoho; 2006 Nov 15; 33(12):1875-7. PubMed ID: 17212133
    [Abstract] [Full Text] [Related]

  • 19. [Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors].
    Wan DS, Wu XJ, Pan ZZ, Zhou ZW, Chen G, Li LR, Lu ZH, Ding PR.
    Zhonghua Yi Xue Za Zhi; 2006 Nov 21; 86(43):3064-7. PubMed ID: 17288838
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.